Tillman Hartley LLC’s AbbVie ABBV Stock Holding History

Tillman Hartley LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$739K	Sell	2,937 -37	-1%	-$7.96K	0.17%	54
2026 Q1	$647K	Sell	2,974 -522	-15%	-$116K	0.16%	57
2025 Q4	$799K	Buy	3,496 +121	+4%	+$27.6K	0.2%	52
2025 Q3	$781K	Buy	3,375 +129	+4%	+$26.3K	0.2%	52
2025 Q2	$603K	Buy	3,246 +160	+5%	+$29.7K	0.17%	57
2025 Q1	$647K	Sell	3,086 -880	-22%	-$171K	0.19%	48
2024 Q4	$705K	Sell	3,966 -160	-4%	-$29.4K	0.2%	48
2024 Q3	$815K	Hold	4,126	–	–	0.24%	40
2024 Q2	$708K	Sell	4,126 -418	-9%	-$69.2K	0.24%	42
2024 Q1	$827K	Sell	4,544 -93	-2%	-$16K	0.28%	36
2023 Q4	$719K	Hold	4,637	–	–	0.27%	38
2023 Q3	$691K	Sell	4,637 -771	-14%	-$113K	0.28%	38
2023 Q2	$729K	Hold	5,408	–	–	0.29%	36
2023 Q1	$862K	Hold	5,408	–	–	0.37%	31
2022 Q4	$874K	Buy	+5,408	New	+$829K	0.38%	30

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tillman Hartley LLC's ABBV Position: Q2 2026 in Review

Tillman Hartley LLC reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $7.96K and leaving 2,937 shares worth $739K. The position accounts for 0.17% of the portfolio, ranked #54.

Tillman Hartley LLC first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $874K in Q4 2022. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Tillman Hartley LLC held 2,937 shares of AbbVie worth $739K as of Q2 2026.
Tillman Hartley LLC sold 37 AbbVie shares in Q2 2026, an estimated $7.96K.
AbbVie made up 0.17% of Tillman Hartley LLC's portfolio in Q2 2026, its #54 holding.
Tillman Hartley LLC first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
Tillman Hartley LLC's AbbVie position peaked at $874K in Q4 2022.
4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tillman Hartley LLC's 13F filing for Q2 2026, filed 6 Aug 2026.